Share This Page
Drug Price Trends for NDC 51407-0012
✉ Email this page to a colleague
Average Pharmacy Cost for 51407-0012
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51407-0012
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| SUMATRIPTAN SUCCINATE 50MG TAB | Golden State Medical Supply, Inc. | 51407-0012-09 | 9 | 9.01 | 1.00111 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 51407-0555
Introduction
The pharmaceutical industry is undergoing significant transformations driven by technological advancements, regulatory changes, and evolving market dynamics. This article will focus on the market analysis and price projections for the drug identified by the National Drug Code (NDC) 51407-0555, which is manufactured by Golden State Medical Supply, Inc.
Drug Details
The NDC 51407-0555 corresponds to Zolpidem Tartrate 12.5mg tablets, a medication used for the short-term treatment of insomnia. This drug is listed in the FDA's NDC Directory, ensuring compliance and transparency[1].
Market Trends in the Pharmaceutical Industry
Gene Therapy and Advanced Treatments
Gene therapy is a rapidly growing area in healthcare, with over 280 therapies in various stages of development. While these advanced treatments are transformative, they often come with high costs, which can influence overall drug price inflation. However, the projected overall drug price inflation rate for 2025 is expected to be around 0.00%, indicating a stable pricing environment for many drugs[3].
Digital Tools and Connected Healthcare
The integration of digital health technologies is making healthcare more connected and efficient. Tools such as pills that send data to doctors and treatments tailored to individual genetic codes are becoming more common. These technologies can improve patient care and reduce healthcare costs in the long run, potentially stabilizing or reducing prices for drugs like Zolpidem Tartrate[1].
Regulatory and Transparency Trends
The FDA's National Drug Code (NDC) Directory plays a crucial role in tracking and regulating drug products. Compliance with FDA regulations is essential for maintaining market presence and can lead to stable pricing due to the transparency and trust built through regulatory adherence[1][4].
Sustainability and Eco-Friendliness
Pharmaceutical companies are increasingly focusing on sustainable practices, including the development, supply chain, and manufacturing processes. Companies that adopt sustainable practices are likely to gain a competitive edge in the market, which could influence pricing strategies as consumers and healthcare providers prefer products from companies with strong sustainability credentials[1].
Market Projections for NDC 51407-0555
Pricing Stability
Given the overall stable drug price inflation rate projected for 2025, it is likely that the price of Zolpidem Tartrate (NDC 51407-0555) will remain relatively stable. As of the latest data, the wholesale price for this drug is around $0.191 per unit, available to the US Federal Government[1].
Impact of Digital Health Technologies
The integration of digital health technologies could enhance the market appeal of Zolpidem Tartrate. For instance, if the drug is combined with digital tools that monitor patient adherence or side effects, it could lead to better patient outcomes and potentially stabilize or reduce prices in the long run[1].
Regulatory Compliance
The drug's listing in the FDA's NDC Directory ensures compliance and transparency, which are crucial for maintaining stable pricing. Proper regulatory adherence builds trust and can mitigate price volatility[1][4].
Competitive Market Dynamics
The market for insomnia treatments is competitive, with several drugs available. However, the specific market positioning of Zolpidem Tartrate, including its pricing and the reputation of Golden State Medical Supply, Inc., will influence its market share. Companies that adopt sustainable practices and leverage digital health technologies may have an edge in this competitive landscape[1][3].
Biopharma and Biotech Industry Trends
The biopharma and biotech industries are experiencing rapid growth, with a projected compound annual growth rate (CAGR) of 7.56% for biopharma and 9.4% for biotech between 2021 and 2027. While Zolpidem Tartrate is not a biologic product, the overall trends in these industries can influence the broader pharmaceutical market. Innovations in clinical trial designs, regulatory frameworks, and the adoption of AI and precision medicine are shaping the future of drug development and pricing[3].
Global Pricing Comparisons
Prescription drug prices in the U.S. are significantly higher than in other countries. For example, prices in the U.S. are 5.5 times those in the OECD (excluding the U.S.) and 7.7 times prices in the rest of the world (excluding the U.S.). This disparity highlights the unique pricing environment in the U.S. and the potential for different pricing strategies based on geographic markets[4].
FAQs
What is the current wholesale price for NDC 51407-0555?
The current wholesale price for Zolpidem Tartrate (NDC 51407-0555) is around $0.191 per unit, available to the US Federal Government[1].
How will digital health technologies impact the pricing of NDC 51407-0555?
Digital health technologies can improve patient care and reduce healthcare costs, potentially stabilizing or reducing prices for drugs like Zolpidem Tartrate[1].
What is the projected overall drug price inflation rate for 2025?
The projected overall drug price inflation rate for 2025 is expected to be around 0.00%, indicating a stable pricing environment[3].
How does regulatory compliance affect the pricing of NDC 51407-0555?
Regulatory compliance ensures transparency and trust, which can stabilize prices by building trust and ensuring adherence to FDA regulations[1][4].
What role will sustainability play in the pricing strategies of pharmaceutical companies in 2025?
Companies that adopt sustainable practices are likely to gain a competitive edge, which could influence pricing strategies as consumers and healthcare providers prefer products from companies with strong sustainability credentials[1].
Key Takeaways
- Stable Pricing Environment: The projected overall drug price inflation rate for 2025 is expected to be around 0.00%, indicating a stable pricing environment for many drugs, including Zolpidem Tartrate (NDC 51407-0555).
- Digital Health Technologies: The integration of digital health technologies can enhance market appeal and potentially stabilize or reduce prices.
- Regulatory Compliance: Compliance with FDA regulations is crucial for maintaining market presence and stable pricing.
- Sustainability: Adopting sustainable practices can provide a competitive edge and influence pricing strategies.
- Global Pricing Disparities: U.S. drug prices are significantly higher than in other countries, highlighting the need for tailored pricing strategies based on geographic markets.
FAQs
What is the impact of AI on the pharmaceutical industry by 2025?
AI is expected to become a standard tool in clinical development, accelerating drug discovery and reducing costs, with adoption rates predicted to double by 2025[3].
How will gene therapy affect the pharmaceutical market in 2025?
Gene therapy will continue to transform healthcare with over 280 therapies in development, but it will also introduce high costs, necessitating sustainable financial models[3].
What is the projected overall drug price inflation rate for 2025?
The projected overall drug price inflation rate for 2025 is expected to be around 0.00%, indicating a stable pricing environment[3].
How does the FDA's NDC Directory impact drug pricing?
The NDC Directory ensures transparency and compliance, which can stabilize prices by building trust and ensuring regulatory adherence[1][4].
What role will sustainability play in the pricing strategies of pharmaceutical companies in 2025?
Companies that adopt sustainable practices are likely to gain a competitive edge, which could influence pricing strategies as consumers and healthcare providers prefer products from companies with strong sustainability credentials[1].
Sources
- DrugPatentWatch: Latest drug prices and trends for NDC 51407-0555.
- DrugPatentWatch: Latest drug prices and trends for NDC 51407-0169.
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
- ASPE: ISSUE BRIEF - International Market Size and Prices.
- FindACode: Golden State Medical Supply, Inc. - List of Drugs - NDC Labeler.
More… ↓
